Company intelligence / Profile preview

Epicutis

Boulder, CO, United Statesepicutis.com ↗

Ownership: Private
Development stage: Commercial

Overview

Clinical studies cited for key ingredients such as TSC demonstrate reduced erythema and dryness in human subjects. The brand emphasizes science-backed efficacy with published pilot studies on their actives. Products are available through clinician offices.

Therapeutic areas: DermatologyImmunology
Modalities: Topical small molecules (e.g., TSC, DSD)Botanical extracts (e.g., Hyvia® from chia seed oil)Antioxidants and lipid mimetics
Industry: Non-Drug Biotech

Drug pipeline

2 assets

Lipid Serum

Commercial

Indications: Skin health, Skin texture

1 more asset in the full pipeline.

Request access →

Partnerships

HydraFacial—partnership for advanced spa/medical skincare delivery systems.

Beyond the preview

Go deeper on Epicutis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epicutis.

Explore the full profile